{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:45:24Z","timestamp":1785415524336,"version":"3.56.0"},"reference-count":37,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Biotechnology","award":["BT\/PR40241\/BTIS-137\/70\/2023"],"award-info":[{"award-number":["BT\/PR40241\/BTIS-137\/70\/2023"]}]},{"award":["BT\/PR40241\/BTIS-137\/70\/2023"],"award-info":[{"award-number":["BT\/PR40241\/BTIS-137\/70\/2023"]}],"id":[{"id":"https:\/\/ror.org\/03tjsyq23","id-type":"ROR","asserted-by":"publisher"}]},{"name":"DBT-BUILDER","award":["BT\/INF\/22\/SP45402\/2022"],"award-info":[{"award-number":["BT\/INF\/22\/SP45402\/2022"]}]},{"DOI":"10.13039\/501100001409","name":"DST-FIST","doi-asserted-by":"publisher","award":["SR\/FST\/LS-II\/2019\/615"],"award-info":[{"award-number":["SR\/FST\/LS-II\/2019\/615"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ICMR-CAR","award":["EMDR\/CARE\/9\/2022-0000430"],"award-info":[{"award-number":["EMDR\/CARE\/9\/2022-0000430"]}]},{"name":"BioIT center at IBAB, Department of IT, BT & ST, GoK"},{"DOI":"10.13039\/501100001412","name":"Council of Scientific & Industrial Research","doi-asserted-by":"crossref","award":["09\/1086(15302)\/2022-EMR-I"],"award-info":[{"award-number":["09\/1086(15302)\/2022-EMR-I"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"crossref"}]},{"award":["09\/1086(15302)\/2022-EMR-I"],"award-info":[{"award-number":["09\/1086(15302)\/2022-EMR-I"]}],"id":[{"id":"https:\/\/ror.org\/021wm7p51","id-type":"ROR","asserted-by":"publisher"}]},{"name":"University Grants Commission","award":["211610169085"],"award-info":[{"award-number":["211610169085"]}]},{"award":["211610169085"],"award-info":[{"award-number":["211610169085"]}],"id":[{"id":"https:\/\/ror.org\/04p800546","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Heat shock protein 90 (HSP90) is a molecular chaperone essential for maintaining the stability of many oncogenic client proteins. Although several HSP90 inhibitors (HSP90i) have entered clinical trials, their use has been limited by toxicity and resistance, underscoring the need for improved therapeutic strategies. In this study, we assessed the therapeutic potential of a new HSP90i, SP11, in T-cell acute lymphoblastic leukemia (T-ALL) in vitro and in the DLA mouse model in vivo, using single-cell transcriptomic profiling. Single-cell RNA sequencing showed that SP11 treatment reduces key oncogenic drivers, including MYC, BCL2, and stemness-related genes, consistent with impaired leukemic survival programs. In the DLA mouse model, SP11-mediated HSP90 inhibition was associated with alterations in the tumor microenvironment, including increased immune cell representation and enrichment of cytokine- and antigen-presentation-related transcriptional pathways. Despite these antitumor effects, a distinct subpopulation of cells continued to express or re-express MYC and BCL2, suggesting the development of early adaptive resistance. Consistent with these findings, an SP11-resistant MOLT4 cell line maintained high levels of MYC and BCL2 at both the transcript and protein levels, maintained CD44 expression, and exhibited altered inflammatory cytokine signaling. Functional studies confirmed that pharmacological inhibition of BCL2 notably increased SP11 sensitivity, supporting a rational combination strategy. Collectively, our results show that SP11 may exert both tumor-intrinsic and immune-modulating effects and reveal transcriptionally defined adaptive cellular states linked to resistance. This study provides mechanistic in sights into responses to HSP90 inhibition and supports combination approaches for improving therapeutic outcomes in T-ALL.<\/jats:p>","DOI":"10.3390\/ijms27125321","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T09:49:51Z","timestamp":1781257791000},"page":"5321","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-Cell Transcriptomic Profiling Reveals Dual Antitumor and Adaptive Resistance Mechanisms of a Novel HSP90 Inhibitor, SP11, in T-Cell Acute Lymphoblastic Leukemic Cells and DLA Mouse Model"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6450-5165","authenticated-orcid":false,"given":"Shahana","family":"M V","sequence":"first","affiliation":[{"name":"Center for Doctoral Studies, Manipal Academy of Higher Education, Manipal 576104, India"},{"name":"Institute of Bioinformatics and Applied Biotechnology, Electronics City, Phase I, Bengaluru 560100, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjitha","family":"R","sequence":"additional","affiliation":[{"name":"Center for Doctoral Studies, Manipal Academy of Higher Education, Manipal 576104, India"},{"name":"Institute of Bioinformatics and Applied Biotechnology, Electronics City, Phase I, Bengaluru 560100, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibha","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics and Applied Biotechnology, Electronics City, Phase I, Bengaluru 560100, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute Lymphoblastic Leukemia in Children","volume":"373","author":"Hunger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41408-022-00613-9","article-title":"Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins","volume":"12","author":"Dourthe","year":"2022","journal-title":"Blood Cancer J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukaemia","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s43018-024-00863-5","article-title":"A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia","volume":"6","author":"Xu","year":"2025","journal-title":"Nat. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.biocel.2012.08.022","article-title":"Cancer Stem Cells","volume":"44","author":"Yu","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"102143","DOI":"10.1016\/j.esmoop.2023.102143","article-title":"PP053 SP11, a promising coumarin-imidazothiadiazole derivative, targets HSP90 and client proteins to inhibit tumor growth","volume":"8","author":"Mv","year":"2023","journal-title":"ESMO Open"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Nirgude, S., Shahana, M.V., Ravindran, F., Kumar, S., Sharma, S., Mahadeva, R., Mhatre, A., Karki, S.S., and Choudhary, B. (2023). A Coumarin-Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins. Molecules, 28.","DOI":"10.3390\/molecules28135226"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1002\/1878-0261.13319","article-title":"MYC and therapy resistance in cancer: Risks and opportunities","volume":"16","author":"Donati","year":"2022","journal-title":"Mol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1038\/s41598-018-24631-5","article-title":"Prognostic significances of overexpression MYC and\/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: A Systematic review and meta-analysis","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3960\/jslrt.51.7","article-title":"BCL2 and MYC dual-hit lymphoma\/leukemia","volume":"51","author":"Tomita","year":"2011","journal-title":"J. Clin. Exp. Hematop."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10147-025-02782-6","article-title":"HSP90 and the cancer transcriptome: A comprehensive review of inhibitors and mechanistic insights","volume":"30","author":"Shahana","year":"2025","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41416-019-0664-6","article-title":"The therapeutic potential of targeting tryptophan catabolism in cancer","volume":"122","author":"Opitz","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exphem.2021.05.006","article-title":"ZFP36L1 plays an ambiguous role in the regulation of cell expansion and negatively regulates CDKN1A in chronic myeloid leukemia cells","volume":"99","author":"Kaehler","year":"2021","journal-title":"Exp. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hu, J., Cao, J., Huang, S., and Chen, Y. (2025). ITGAX promotes gastric cancer progression via epithelial-mesenchymal transition pathway. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1536478"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.18632\/oncotarget.3372","article-title":"Free ISG15 triggers an antitumor immune response against breast cancer: A new perspective","volume":"6","author":"Burks","year":"2015","journal-title":"Oncotarget"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e1052935","DOI":"10.1080\/2162402X.2015.1052935","article-title":"ISG15: A double edged sword in cancer","volume":"4","author":"Desai","year":"2015","journal-title":"Oncoimmunology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.7150\/thno.45058","article-title":"C5aR1 is a master regulator in Colorectal Tumorigenesis via Immune modulation","volume":"10","author":"Ding","year":"2020","journal-title":"Theranostics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41419-025-07464-9","article-title":"Tumor cell-derived EMP1 is essential for cancer-associated fibroblast infiltration in tumor microenvironment of triple-negative breast cancer","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"106827","DOI":"10.1016\/j.isci.2023.106827","article-title":"Reprogramming of iron metabolism confers ferroptosis resistance in ECM-detached cells","volume":"26","author":"He","year":"2023","journal-title":"iScience"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lee, N.-H., Park, S.-R., Lee, J.W., Lim, S., Lee, S.-H., Nam, S., Kim, D.Y., Hah, S.Y., Hong, I.-S., and Lee, H.-Y. (2019). SERPINB2 Is a Novel Indicator of Cancer Stem Cell Tumorigenicity in Multiple Cancer Types. Cancers, 11.","DOI":"10.3390\/cancers11040499"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zhang, J., Yang, L., Xu, B., Ji, H., Liu, S., Wang, X., Li, X., Wang, Q., and Song, Z. (2024). The role of ATP6V0D2 in breast cancer: Associations with prognosis, immune characteristics, and TNBC progression. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1511810"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"102077","DOI":"10.1016\/j.tranon.2024.102077","article-title":"Cytochrome P450 F3 promotes colorectal cancer via inhibiting NRF2-mediated ferroptosis","volume":"48","author":"Xu","year":"2024","journal-title":"Transl. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1101\/gad.350314.122","article-title":"SPOC domain proteins in health and disease","volume":"37","author":"Appel","year":"2023","journal-title":"Genes Dev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1021\/acsptsci.4c00473","article-title":"Exploring G Protein-Coupled Receptors in Hematological Cancers","volume":"7","author":"Tsang","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.trecan.2017.06.003","article-title":"\u03b3\u03b4T Cells: Unexpected Regulators of Cancer Development and Progression","volume":"3","author":"Fleming","year":"2017","journal-title":"Trends Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s12276-021-00576-0","article-title":"Function of \u03b3\u03b4 T cells in tumor immunology and their application to cancer therapy","volume":"53","author":"Park","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12967-017-1378-2","article-title":"Gamma-delta (\u03b3\u03b4) T cells: Friend or foe in cancer development?","volume":"16","author":"Zhao","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"902442","DOI":"10.1517\/13543784.2014.902442","article-title":"Heat shock protein 90 inhibitors in the treatment of cancer: Current status and future directions","volume":"23","author":"Jhaveri","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/1078-0432.CCR-11-1000","article-title":"Hsp90 molecular chaperone inhibitors: Are we there yet?","volume":"18","author":"Neckers","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3324\/haematol.2012.066175","article-title":"The PI3K\/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma","volume":"98","author":"Chatterjee","year":"2013","journal-title":"Haematologica"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3892\/or.2017.5797","article-title":"Hsp90 inhibitor induces KG-1a cell differentiation and apoptosis via Akt\/NF-\u03baB signaling","volume":"38","author":"Qin","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1002\/mco2.470","article-title":"Heat shock protein 90: Biological functions, diseases, and therapeutic targets","volume":"5","author":"Wei","year":"2024","journal-title":"MedComm"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41467-017-00449-z","article-title":"HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes","volume":"8","author":"Mbofung","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chembiol.2020.10.005","article-title":"HSP90 Inhibition Enhances Cancer Immunotherapy by Modulating the Surface Expression of Multiple Immune Checkpoint Proteins","volume":"28","author":"Zavareh","year":"2021","journal-title":"Cell Chem. Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5321\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T04:17:02Z","timestamp":1781410622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27125321"],"URL":"https:\/\/doi.org\/10.3390\/ijms27125321","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}